Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Terminated 2Withdrawn 1Recruiting 1No longer available 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 15Leukemia, Lymphocytic, Chronic, B-Cell 11Burkitt Lymphoma 10Lymphoma 9Leukemia 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Follicular 8Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Myelodysplastic Syndromes 6Multiple Myeloma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Hematologic Neoplasms 4Congenital Abnormalities 4Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Biphenotypic, Acute 3Waldenstrom Macroglobulinemia 2Recurrence 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2

Interventions

Idarubicin 2Cytarabine 2fludarabine phosphate 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Isotretinoin 1Interferon-alpha 1Idoxuridine 1Drug Therapy 1Bromodeoxyuridine 1Biological Therapy 1BI 6727 1Arsenic Trioxide 1Antilymphocyte Serum 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myelomonocytic, Acute × fludarabine phosphate × Clear all
NCT00101140 2017-10-19

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡